Pharma Review sp. z o.o.
Other out-of-school forms of education, not elsewhere classified
Overview
Financials
Revenue history (in k)
Filing timeliness
No financial statement for 2023 – the filing deadline has passed. 5 of 5 financial statements were filed late (the longest delay 533 days for 2018).
- 2023not filed
- 202201/08/2023
- 202101/08/2023
- 202004/05/2022
- 201929/12/2020
- 201829/12/2020
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2022.
Results vs industry
Industry
Public procurement
No recorded participation in tenders.
The company is the contractor in 2 public sector contracts, worth USD 640.19 in total. They were signed with 2 public buyers.
| Signed on | Subject | Amount | Public buyer | |
|---|---|---|---|---|
| Nov 12, 2026 | Training: "Zezwolenie na wytwarzanie lub import produktów leczniczych" | $426.80 | Regionalne Centrum Krwiodawstwa I Krwiolecznictwa w Białymstoku | |
| Oct 20, 2026 | Training - new CLP hazard classes | $213.40 | Wojewódzki Inspektorat Weterynarii w Olsztynie |
Authorized Representatives
Manner of representation
Each member of the management board independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 100 | $1,350.62 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Was a VAT taxpayer from 2014-03-27 to 2024-07-01.
Reason for removal: Art. 96 ust. 9a pkt 1 (business activity suspended for at least 6 consecutive months)
Debt
No entries in the National Debtors Register (KRZ).
Public aid
8 public aid cases recorded, with a total value of $49,338.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Feb 1, 2021 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $13,413$13,413 | Polski Fundusz Rozwoju S.A. | |
| Sep 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $1,384$1,384 | Prezes Zakładu Ubezpieczeń Społecznych | |
| Sep 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $1,356$1,356 | Prezes Zakładu Ubezpieczeń Społecznych |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Wszechnica Bezpieczeństwa sp. z o.o. | $53,955.30 | wszechnica.com.pl | ||
| LISA Polska sp. z o.o. | $54,533.84 | podrozejezykowe.pl | ||
| Instytut Maturalny sp. z o.o. | $51,606.50 | instytutmaturalny.com | ||
| Code And Play sp. z o.o. + limited partnership | $50,530.14 | codeandplay.pl | ||
| Edufactory sp. z o.o. | $49,762.02 | edufactory.pl | ||
| Schenk Institute sp. z o.o. | $49,480.65 | schenk.pl | ||
| Liera sp. z o.o. | $49,169.67 | liera.pl | ||
| DAY For Dog Academy sp. z o.o. | $48,997.62 | dayfordog.pl | ||
| PSIE Abc sp. z o.o. | $47,126.40 | psieabc.pl | ||
| Atut-Bm sp. z o.o. | $45,208.73 | atut-bm.pl |
Change history
| Date | Event | |
|---|---|---|
| 2025-11-01 | Business resumed | |
| 2023-10-31 | Business suspended | |
| 2021-10-12 | Address change (Solińska 19 A/5, 02-142, Warszawa → Ul. Rozłucka 12/15, 04-029, Warszawa) | |
| 2017-03-10 | PKD change (Removed: 27 codes; Added: 1 code) | |
| 2014-09-19 | Entered in the register |
FAQ
Last updated: 2026-10-07